Gastrointestinal hormones and gut motility.
To summarize the recent findings. Studies of changes in the plasma levels confirm the earlier concepts, but offer little proof of causal effect. It is increasingly realized that peptides produced in the gut have a paracrine role or an indirect effect via the gut-brain axis. Interest in prokinetic peptide agonists remains high despite the failure of two candidate drugs, but relamorelin and camicinal offer new hope. We review the original studies published since January 2013 on peptides produced in the gut and with an effect on gastrointestinal motility.